These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6770975)

  • 1. Bone mineral status measured by direct photon absorptiometry in institutionalized adults receiving long-term anticonvulsant therapy and multivitamin supplementation.
    Barden HS; Mazess RB; Rose PG; McAweeney W
    Calcif Tissue Int; 1980; 31(2):117-21. PubMed ID: 6770975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone status of children receiving anticonvulsant therapy.
    Barden HS; Mazess RB; Chesney RW; Rose PG; Chun R
    Metab Bone Dis Relat Res; 1982; 4(1):43-7. PubMed ID: 7121254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium metabolism in adult outpatients with epilepsy receiving long-term anticonvulsant therapy.
    Pylypchuk G; Oreopoulos DG; Wilson DR; Harrison JE; McNeill KG; Meema HE; Ogilvie R; Sturtridge WC; Murray TM
    Can Med Assoc J; 1978 Mar; 118(6):635-8. PubMed ID: 418865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticonvulsant drugs and bone metabolism.
    Bogliun G; Beghi E; Crespi V; Delodovici L; d'Amico P
    Acta Neurol Scand; 1986 Oct; 74(4):284-8. PubMed ID: 3811834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone mineral in mentally retarded patients receiving long-term anticonvulsive therapy.
    Barden HS; Smith E
    Growth; 1975 Sep; 39(3):371-88. PubMed ID: 1183855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased serum ionized calcium and normal vitamin D metabolite levels with anticonvulsant drug treatment.
    Weinstein RS; Bryce GF; Sappington LJ; King DW; Gallagher BB
    J Clin Endocrinol Metab; 1984 Jun; 58(6):1003-9. PubMed ID: 6725504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone status in nonambulant, epileptic, institutionalized youth. Improvement with vitamin D therapy.
    Fischer MH; Adkins WN; Liebl BH; VanCalcar SC; Marlett JA
    Clin Pediatr (Phila); 1988 Oct; 27(10):499-505. PubMed ID: 2844466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteomalacia in institutionalized epileptic patients on long-term anticonvulsant therapy.
    Hoikka V; Savolainen K; Alhava EM; Sivenius J; Karjalainen P; Repo A
    Acta Neurol Scand; 1981 Aug; 64(2):122-31. PubMed ID: 7324878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of anticonvulsant drug therapy on bone mineral density in a pediatric population.
    Timperlake RW; Cook SD; Thomas KA; Harding AF; Bennett JT; Haller JS; Anderson RM
    J Pediatr Orthop; 1988; 8(4):467-70. PubMed ID: 3392200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiology behind anticonvulsant osteomalacia.
    Christiansen C; Rødbro P; Tjellesen L
    Acta Neurol Scand Suppl; 1983; 94():21-8. PubMed ID: 6576595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bone mineral content measurement by a radiographic method. II. Bone mineral content measurement of the ulna in epileptics on long-term anticonvulsant therapy].
    Lian ZC
    Zhonghua Fang She Xue Za Zhi; 1983 May; 17(2):110-3. PubMed ID: 6226501
    [No Abstract]   [Full Text] [Related]  

  • 12. [Long-term anticonvulsant therapy and calcium and phosphorus metabolism].
    Bergonzi P; De Rosa G; Mazza S; Mennuni G; Zuppi PL
    Riv Neurol; 1979; 49(1):72-81. PubMed ID: 451400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of anticonvulsant osteomalacia and effect of vitamin D: controlled therapeutic trial.
    Christiansen C; Rodbro P; Lund M
    Br Med J; 1973 Dec; 4(5894):695-701. PubMed ID: 4776883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of seizure control due to anticonvulsant-induced hypocalcemia.
    Ali FE; Al-Bustan MA; Al-Busairi WA; Al-Mulla FA
    Ann Pharmacother; 2004 Jun; 38(6):1002-5. PubMed ID: 15084684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of hypocalcemia and elevated serum alkaline phosphatase in patients receiving chronic anticonvulsant therapy.
    Schmitt BP; Nordlund DJ; Rodgers LA
    J Fam Pract; 1984 Jun; 18(6):873-7. PubMed ID: 6726133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of oxcarbazepine on bone metabolism.
    Cetinkaya Y; Kurtulmuş YS; Tutkavul K; Tireli H
    Acta Neurol Scand; 2009 Sep; 120(3):170-5. PubMed ID: 19719808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperpyrexia secondary to acute hypocalcemic status. Is there a role for calcitonin therapy in bone metabolism derangements due to anticonvulsant drugs?
    Alexandropoulou P; Mauri D; Rigatou E; Karampoiki V
    Minerva Med; 2000; 91(11-12):321-3. PubMed ID: 11253715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased circulating levels of gamma-carboxyglutamic acid-containing protein and decreased bone mass in children on anticonvulsant therapy.
    Takeshita N; Seino Y; Ishida H; Seino Y; Tanaka H; Tsutsumi C; Ogata K; Kiyohara K; Kato H; Nozawa M
    Calcif Tissue Int; 1989 Feb; 44(2):80-5. PubMed ID: 2492894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of topiramate monotherapy on bone mineral density and markers of bone and mineral metabolism in premenopausal women with epilepsy.
    Heo K; Rhee Y; Lee HW; Lee SA; Shin DJ; Kim WJ; Song HK; Song K; Lee BI
    Epilepsia; 2011 Oct; 52(10):1884-9. PubMed ID: 21692779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disordered mineral metabolism produced by ketogenic diet therapy.
    Hahn TJ; Halstead LR; DeVivo DC
    Calcif Tissue Int; 1979 Aug; 28(1):17-22. PubMed ID: 115548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.